Building on the success of previous Swine Expert Forum meetings, again 60 key stakeholders from science, retailers, slaughter houses, producers and the veterinary field from all over the world came together to exchange their knowledge, expertise and experience to tackle a burning issue for everyone involved in swine production. As the global market leader in pig vaccines Boehringer Ingelheim each year is providing a unique platform to foster exchange and share scientific information. In a workshop important trends in global pig production and what these mean for the role of the pig food chain for sustainable food production are being discussed.
Building on the success of previous Swine Expert Forum meetings, again 60 key stakeholders from science, retailers, slaughter houses, producers and the veterinary field from all over the world came together to exchange their knowledge, expertise and experience to tackle a burning issue for everyone involved in swine production.
Read and download the posters.
Here you can read and download some of the posters presented during IPVS 2016 in Dublin
During the last fifty years or so, disease control in the pork industry has evolved mainly relying on antimicrobials, vaccines, elimination (depopulation, repopulation, eradication, modified early weaning), and/or regional control depending on the disease.
Should a piglet fail to ingest any colostrum, its chance of survival is almost zero!
The concentrations of immunoglobulin (IgG and IgA) decrease rapidly within a few hours of birth. The timing and quantity of colostrum-intake are therefore critical. The more the better, the quicker the better!
Boehringer Ingelheim Animal Health GmbH, have announced the pan-European launch of Enterisol® Ileitis, the first enteric vaccine to have received marketing authorization in the EU to improve pig’s weight gain and to reduce body weight variability. From now on, Enterisol® Ileitis is available in 19 European countries.
Get the latest news on Swine Health Subscribe to our newsletter